Neurologists' attitudes regarding rt-PA for acute ischemic stroke

被引：19
|
作者：
Villar-Cordova, C
Morgenstern, LB
Barnholtz, JS
Grotta, JC
机构：
[1] Univ Texas, Sch Med, Dept Neurol, Houston, TX 77030 USA
[2] Univ Texas, Sch Publ Hlth, Dept Biometry, Houston, TX 77025 USA
[3] Univ Texas, Sch Publ Hlth, Epidemiol Res Ctr, Houston, TX 77025 USA
来源：
NEUROLOGY | 1998年 / 50卷 / 05期
关键词：
D O I：
10.1212/WNL.50.5.1491
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
We studied the attitudes of 238 Texas neurologists regarding the use of recombinant tissue plasminogen activator (rt-PA). The results show that 38 (16%) had treated stroke patients with rt-PA, and 97% of these would do so again. In the group that had not treated patients, 60% would treat if a suitable candidate presented. We conclude that soon after FDA approval of rt-PA, two-thirds of survey respondents were using or were planning to use this therapy. Those neurologists who have used ct-PA for stroke report a positive experience.
引用
收藏
页码：1491 / 1494
页数：4
相关论文
共 50 条
  • [11] Absolute and Relative Contraindications to IV rt-PA for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    NEUROHOSPITALIST, 2015, 5 (03): : 110 - 121
  • [12] Extraischemic Hematomas Following Intravenous rt-PA For Acute Ischemic Stroke
    Osaki, Masato
    Koga, Masatoshi
    Fukuda, Mayumi
    Shigehatake, Yuya
    Nagatsuka, Kazuyuki
    Minematsu, Kazuo
    Toyoda, Kazunori
    STROKE, 2013, 44 (02)
  • [13] Intravenous rt-PA versus endovascular therapy for acute ischemic stroke
    Pitchaiah Mandava
    Jose I. Suarez
    Thomas A. Kent
    Current Atherosclerosis Reports, 2008, 10 : 332 - 338
  • [14] Intravenous rt-PA versus Endovascular Therapy for Acute Ischemic Stroke
    Mandava, Pitchaiah
    Suarez, Jose I.
    Kent, Thomas A.
    CURRENT ATHEROSCLEROSIS REPORTS, 2008, 10 (04) : 332 - 338
  • [15] Antiphospholipid antibodies and outcome of acute ischemic stroke in the NINDS rt-PA stroke trial
    Tanne, D
    Levine, SR
    Brey, RL
    Lin, H
    Tilley, BC
    STROKE, 2003, 34 (01) : 279 - 279
  • [16] US Geographic Distribution of Rt-PA Utilization for Acute Ischemic Stroke by Hospital
    Kleindorfer, Dawn
    Xu, Yingying
    Khatri, Pooja
    Adeoye, Opeolu
    Hornung, Richard
    STROKE, 2009, 40 (04) : E160 - E160
  • [17] Evaluation of Acute Ischemic Stroke Patients with rt-PA Intravenous Therapy by Age
    Yunoki, T.
    Kono, S.
    Narai, H.
    Omori, N.
    Manabe, Y.
    CEREBROVASCULAR DISEASES, 2016, 42 : 68 - 69
  • [18] ANALYSIS OF THE CLINICAL EFFICACY AND SAFETY OF RT-PA IN TREATMENT OF ACUTE ISCHEMIC STROKE
    Wu, Junyi
    Zing, Xiaoyun
    Luo, Zhixiu
    Zhou, Jie
    ACTA MEDICA MEDITERRANEA, 2019, 35 (02): : 765 - 769
  • [19] Simultaneous administration of edaravone and RT-PA in acute cerebral ischemic stroke patients
    Takenaka, K.
    Kato, M.
    Yamauchi, K.
    Nonaka, Y.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 : 98 - 98
  • [20] Cognitive deficits in acute mild ischemic stroke and TIA and effects of rt-PA
    Halevi, David Rosenbaum
    Bursaw, Andrew W.
    Karamchandani, Rahul R.
    Alderman, Susan E.
    Breier, Joshua I.
    Vahidy, Farhaan S.
    Aden, James K.
    Cai, Chunyan
    Zhang, Xu
    Savitz, Sean I.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (03): : 466 - 474
12345